XML 313 R56.htm IDEA: XBRL DOCUMENT
v3.24.3

Share-Based Compensation (Tables) | 6 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2024 | Mar. 31, 2024
Summary Of Share-Based Compensation Expense | The Company recognized the following share-based compensation expense during the three and six months ended September 30, 2024 and 2023:
|  | Three Months Ended September 30, |  |  | Six Months Ended September 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
|  | (Amounts in millions) |
Compensation Expense: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options |  | $ | 0.2 |  |  | $ | 0.5 |  |  | $ | 0.4 |  |  | $ | 0.9 |
Restricted share units and other share-based compensation |  |  | 8.2 |  |  |  | 12.9 |  |  |  | 16.3 |  |  |  | 20.3 |
Share appreciation rights |  |  | 0.2 |  |  |  | 0.1 |  |  |  | 0.3 |  |  |  | 0.2 |
Total Lionsgate Studios employee share-based compensation expense |  |  | 8.6 |  |  |  | 13.5 |  |  |  | 17.0 |  |  |  | 21.4 |
Corporate allocation of share-based compensation |  |  | 6.7 |  |  |  | 3.9 |  |  |  | 10.9 |  |  |  | 7.6 |
|  |  | 15.3 |  |  |  | 17.4 |  |  |  | 27.9 |  |  |  | 29.0 |
Impact of accelerated vesting on equity awards (1) |  |  | 4.6 |  |  |  | — |  |  |  | 4.6 |  |  |  | 0.5 |
Total share-based compensation expense |  | $ | 19.9 |  |  | $ | 17.4 |  |  | $ | 32.5 |  |  | $ | 29.5 |
(1) | Represents the impact of the acceleration of vesting schedules for equity awards pursuant to certain severance arrangements prior to the Separation.
Share-based compensation expense, by expense category, consisted of the following:
|  | Three Months Ended September 30, |  |  | Six Months Ended September 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
|  | (Amounts in millions) |
Share-Based Compensation Expense: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
General and administration |  | $ | 15.3 |  |  | $ | 17.4 |  |  | $ | 27.9 |  |  | $ | 29.0 |
Restructuring and other |  |  | 4.6 |  |  |  | — |  |  |  | 4.6 |  |  |  | 0.5 |
|  | $ | 19.9 |  |  | $ | 17.4 |  |  | $ | 32.5 |  |  | $ | 29.5 |
| The Company recognized the following share-based compensation expense during the years ended March 31, 2024, 2023 and 2022:
|  | Year Ended March 31, |
|  | 2024 |  |  | 2023 |  |  | 2022 |
|  | (Amounts in millions) |
Compensation Expense: |  |  |  |  |  |  |  |  |  |  |  |
Stock options |  | $ | 1.7 |  |  | $ | 2.3 |  |  | $ | 9.6 |
Restricted share units and other share-based compensation |  |  | 37.7 |  |  |  | 39.3 |  |  |  | 38.6 |
Share appreciation rights |  |  | 0.4 |  |  |  | 0.9 |  |  |  | 2.4 |
Total Studio employee share-based compensation expense |  |  | 39.8 |  |  |  | 42.5 |  |  |  | 50.6 |
Corporate allocation of share-based compensation |  |  | 15.0 |  |  |  | 26.7 |  |  |  | 19.6 |
|  |  | 54.8 |  |  |  | 69.2 |  |  |  | 70.2 |
Impact of accelerated vesting on equity awards (1) |  |  | 7.7 |  |  |  | 4.2 |  |  |  | — |
Total share-based compensation expense |  |  | 62.5 |  |  |  | 73.4 |  |  |  | 70.2 |
Tax impact (2) |  |  | (15.1 | ) |  |  | (17.8 | ) |  |  | (16.7 | )
Reduction in net income |  | $ | 47.4 |  |  | $ | 55.6 |  |  | $ | 53.5 |
(1) | Represents the impact of the acceleration of vesting schedules for equity awards pursuant to certain severance arrangements.
(2) | Represents the income tax benefit recognized in the statements of operations for share-based compensation arrangements prior to the effects of changes in the valuation allowance.
Summary Of Share-Based Compensation Expense, By Expense Category |  | Share-based compensation expense, by expense category, consisted of the following:
|  | Year Ended March 31, |
|  | 2024 |  |  | 2023 |  |  | 2022 |
|  | (Amounts in millions) |
Share-Based Compensation Expense: |  |  |  |  |  |  |  |  |  |  |  |
General and administration |  | $ | 54.8 |  |  | $ | 69.2 |  |  | $ | 70.2 |
Restructuring and other |  |  | 7.7 |  |  |  | 4.2 |  |  |  | — |
|  | $ | 62.5 |  |  | $ | 73.4 |  |  | $ | 70.2 |
Summary Of Stock Option, And Share Appreciation Rights |  | The following table sets forth the stock option, and share appreciation rights (“SARs”) activity on grants related directly to the Company employees and Lionsgate corporate and shared service employees during the year ended March 31, 2024:
|  | Stock Options and SARs |
|  | Existing Class A Common Stock |  |  | Existing Class B Common Stock |
|  | Number of Shares |  |  | Weighted- Average Exercise Price |  |  | Weighted- Average Remaining Contractual Term (years) |  |  | Aggregate Intrinsic Value (2) |  |  | Number of Shares |  |  | Weighted- Average Exercise Price |  |  | Weighted- Average Remaining Contractual Term (years) |  |  | Aggregate Intrinsic Value (2) |
|  | (Amounts in millions, except for weighted-average exercise price and years) |
Outstanding at March 31, 2023 |  |  | 4.3 |  |  | $ | 26.35 |  |  |  |  |  |  |  |  |  |  |  | 19.0 |  |  | $ | 15.50 |  |  |  |  |  |  |  |  |
Granted |  |  | — |  |  | $ | — |  |  |  |  |  |  |  |  |  |  |  | 0.3 |  |  | $ | 8.88 |  |  |  |  |  |  |  |  |
Exercised |  |  | — | (1) |  | $ | 7.70 |  |  |  |  |  |  |  |  |  |  |  | (0.1 | ) |  | $ | 7.11 |  |  |  |  |  |  |  |  |
Forfeited or expired |  |  | (1.9 | ) |  | $ | 30.81 |  |  |  |  |  |  |  |  |  |  |  | (2.1 | ) |  | $ | 27.72 |  |  |  |  |  |  |  |  |
Outstanding at March 31, 2024 |  |  | 2.4 |  |  | $ | 22.96 |  |  |  | 2.51 |  |  | $ | 0.1 |  |  |  | 17.1 |  |  | $ | 13.92 |  |  |  | 5.12 |  |  | $ | 5.9 |
Vested or expected to vest at March 31, 2024 |  |  | 2.4 |  |  | $ | 22.96 |  |  |  | 2.51 |  |  | $ | 0.1 |  |  |  | 17.0 |  |  | $ | 13.94 |  |  |  | 5.11 |  |  | $ | 5.9 |
Exercisable at March 31, 2024 |  |  | 2.4 |  |  | $ | 22.96 |  |  |  | 2.51 |  |  | $ | 0.1 |  |  |  | 16.4 |  |  | $ | 14.16 |  |  |  | 4.96 |  |  | $ | 5.6 |
(1) | Represents less than 0.1 million shares.
(2) | The intrinsic value is calculated for each in the money stock option and SAR as the difference between the closing price of Lionsgate’s common stock on March 31, 2024 and the exercise price.
Summary Of Weighted Average Grant-Date Fair Value Of Options Granted |  | The fair value of each option award is estimated on the date of grant using a closed-form option valuation model (Black-Scholes). The following table presents the weighted average grant-date fair value of options granted in the years ended March 31, 2024, 2023 and 2022, and the weighted average applicable assumptions used in the Black-Scholes option-pricing model for stock options and share-appreciation rights granted during the years then ended:
|  | Year Ended March 31,
|  | 2024 |  | 2023 |  | 2022
Weighted average fair value of grants |  | $4.63 |  | $4.56 |  | $6.16
Weighted average assumptions: |  |  |  |  |  |
Risk-free interest rate (1) |  | 4.3% - 4.5% |  | 2.8% - 3.7% |  | 1.1% - 2.45%
Expected option lives (in years) (2) |  | 3.3 - 7 years |  | 3.5 - 7 years |  | 3.3 - 7 years
Expected volatility for options (3) |  | 46% - 47% |  | 44% |  | 42% - 44%
Expected dividend yield (4) |  | 0% |  | 0% |  | 0%
(1) | The risk-free rate assumed in valuing the options is based on the U.S. Treasury Yield curve in effect applied against the expected term of the option at the time of the grant.
(2) | The expected term of options granted represents the period of time that options granted are expected to be outstanding.
(3) | Expected volatilities are based on implied volatilities from traded options on Lionsgate’s shares, historical volatility of Lionsgate’s shares and other factors.
(4) | The expected dividend yield is estimated by dividing the expected annual dividend by the market price of Lionsgate’s shares at the date of grant.
The total intrinsic value (based on Lionsgate’s share price) of options exercised during the year ended March 31, 2024 was $0.2 million (2023— $1.1 million, 2022— $2.1 million ).
Summary Of Restricted Share Unit And Restricted Stock Activity |  | The following table sets forth the restricted share unit and restricted stock activity on grants related directly to Company employees and Lionsgate corporate and shared service employees during the year ended March 31, 2024:
|  | Restricted Share Units and Restricted Stock |
|  | Existing Class A Common Stock |  |  | Weighted- Average Grant- Date Fair Value |  |  | Existing Class B Common Stock |  |  | Weighted- Average Grant- Date Fair Value |
|  | (Amounts in millions, except for weighted-average grant date fair value) |
Outstanding at March 31, 2023 |  |  | — | (1) |  | $ | 10.95 |  |  |  | 10.8 |  |  | $ | 9.90 |
Granted |  |  | 0.1 |  |  | $ | 8.87 |  |  |  | 6.3 |  |  | $ | 8.22 |
Vested |  |  | — | (1) |  | $ | 10.89 |  |  |  | (7.0 | ) |  | $ | 9.37 |
Forfeited |  |  | — |  |  | $ | — |  |  |  | (0.3 | ) |  | $ | 8.64 |
Outstanding at March 31, 2024 |  |  | 0.1 |  |  | $ | 9.27 |  |  |  | 9.8 |  |  | $ | 8.93 |
(1) | Represents less than 0.1 million shares.
The fair values of restricted share units and restricted stock are determined based on the market value of the shares on the date of grant. The total fair value of restricted share units and restricted stock vested during the year ended March 31, 2024 was $67.5 million (2023 - $40.0 million, 2022 - $51.0 million).
Summary Of Total Remaining Unrecognized Compensation Cost |  | The following table summarizes the total remaining unrecognized compensation cost as of March 31, 2024 related to non-vested stock options and restricted stock and restricted share units and the weighted average remaining years over which the cost will be recognized:
|  | Total Unrecognized Compensation Cost |  |  | Weighted Average Remaining Years |
|  | (Amounts in millions) |
Stock Options |  | $ | 2.3 |  |  |  | 1.5 |
Restricted Share Units and Restricted Stock |  |  | 40.5 |  |  |  | 1.6 |
Total (1) |  | $ | 42.8 |  |  |  |  |
(1) | Represents remaining unrecognized compensation cost related to the Company’s employees and an allocation of compensation costs for Lionsgate corporate and shared service employees.
Under Lionsgate’s stock option and long term incentive plans, Lionsgate withholds shares to satisfy minimum statutory federal, state and local tax withholding obligations arising from the vesting of restricted share units and restricted stock. During the year ended March 31, 2024, 3.0 million shares (2023 — 1.5 million shares, 2022—1.8 million shares) were withheld upon the vesting of restricted share units and restricted stock.
Starz Business of Lions Gate Entertainment Corp |  |
Summary Of Share-Based Compensation Expense | The Starz Business recognized the following share-based compensation expense:
|  | Six Months Ended September 30, |
|  | 2024 |  |  | 2023 |
|  | (Amounts in millions) |
Compensation Expense: |  |  |  |  |  |  |  |
Restricted share units |  | $ | 8.6 |  |  | $ | 9.3 |
Corporate allocation of share-based compensation |  |  | 0.7 |  |  |  | 2.8 |
|  |  | 9.3 |  |  |  | 12.1 |
Impact of accelerated vesting on equity awards (1) |  |  | 0.3 |  |  |  | 0.9 |
Total share-based compensation expense (2) |  | $ | 9.6 |  |  | $ | 13.0 |
(1) | Represents the impact of the acceleration of vesting schedules for equity awards pursuant to certain severance arrangements.
(2) | Included in net earnings (loss) from discontinued operations for the six months ended September 30, 2024 was share-based compensation expense of $ 0.3 million (2023 — $ 1.0 million).
| The Starz Business recognized the following share-based compensation expense:
|  | Year Ended March 31, |
|  | 2024 |  |  | 2023 |  |  | 2022 |
|  | (Amounts in millions) |
Compensation Expense: |  |  |  |  |  |  |  |  |  |  |  |
Stock options |  | $ | — |  |  | $ | 0.4 |  |  | $ | 2.2 |
Restricted share units |  |  | 17.6 |  |  |  | 15.7 |  |  |  | 16.9 |
Share appreciation rights |  |  | — |  |  |  | (0.1 | ) |  |  | 1.1 |
Total Starz employee share-based compensation expense |  |  | 17.6 |  |  |  | 16.0 |  |  |  | 20.2 |
Corporate allocation of share-based compensation |  |  | 5.6 |  |  |  | 9.7 |  |  |  | 7.8 |
|  |  | 23.2 |  |  |  | 25.7 |  |  |  | 28.0 |
Impact of accelerated vesting on equity awards (1) |  |  | 1.4 |  |  |  | — |  |  |  | — |
Total share-based compensation expense (2) |  | $ | 24.6 |  |  | $ | 25.7 |  |  | $ | 28.0 |
Tax impact (3) |  |  | (5.9 | ) |  |  | (6.2 | ) |  |  | (6.7 | )
Increase in net loss |  | $ | 18.7 |  |  | $ | 19.5 |  |  | $ | 21.3 |
(1) | Represents the impact of the acceleration of vesting schedules for equity awards pursuant to certain severance arrangements.
(2) | Included in net earnings (loss) from discontinued operations for the year ended March 31, 2024 was share-based compensation expense of $1.8 million (including $0.4 million related to accelerated vesting on equity awards) (2023 — $ 3.0 million, 2022 — $1.9 million).
(3) | Represents the income tax benefit recognized in the statements of operations for share-based compensation arrangements.
Summary Of Share-Based Compensation Expense, By Expense Category | Share-based compensation expense from continuing operations, by expense category, consisted of the following:
|  | Six Months Ended September 30, |
|  | 2024 |  |  | 2023 |
|  | (Amounts in millions) |
Share-Based Compensation Expense: |  |  |  |  |  |  |  |
Direct operating |  | $ | 1.4 |  |  | $ | 1.3 |
Distribution and marketing |  |  | 0.5 |  |  |  | 0.4 |
General and administration |  |  | 7.4 |  |  |  | 10.4 |
Restructuring and other |  |  | 0.3 |  |  |  | 0.9 |
|  | $ | 9.6 |  |  | $ | 13.0 |
| Share-based compensation expense from continuing operations, by expense category, consisted of the following:
|  | Year Ended March 31, |
|  | 2024 |  |  | 2023 |  |  | 2022 |
|  | (Amounts in millions) |
Share-Based Compensation Expense: |  |  |  |  |  |  |  |  |  |  |  |
Direct operating |  | $ | 2.7 |  |  | $ | 1.6 |  |  | $ | 1.2 |
Distribution and marketing |  |  | 0.8 |  |  |  | 0.7 |  |  |  | 0.5 |
General and administration |  |  | 19.7 |  |  |  | 23.4 |  |  |  | 26.3 |
Restructuring and other |  |  | 1.4 |  |  |  | — |  |  |  | — |
|  | $ | 24.6 |  |  | $ | 25.7 |  |  | $ | 28.0 |
Summary Of Stock Option, And Share Appreciation Rights | The following table sets forth the stock option, share appreciation rights (“SARS”) and restricted share unit activity during the six months ended September 30, 2024:
|  | Stock Options and SARs |  |  | Restricted Share Units |
|  | Lionsgate Class B Non-Voting Shares |  |  | Lionsgate Class B Non-Voting Shares |
|  | Number of Shares |  |  | Weighted- Average Exercise Price |  |  | Number of Shares |  |  | Weighted- Average Grant-Date Fair Value |
|  | (Number of shares in millions) |
Outstanding at March 31, 2024 |  |  | 1.3 |  |  | $ | 11.14 |  |  |  | 3.4 |  |  | $ | 8.62 |
Granted |  |  | — |  |  |  | — |  |  |  | 2.2 |  |  | $ | 8.00 |
Options exercised or RSUs vested |  |  | — | (1) |  | $ | 6.49 |  |  |  | (2.2 | ) |  | $ | 8.69 |
Forfeited or expired |  |  | — | (1) |  | $ | 11.99 |  |  |  | (0.1 | ) |  | $ | 8.23 |
Outstanding at September 30, 2024 |  |  | 1.3 |  |  | $ | 11.30 |  |  |  | 3.3 |  |  | $ | 8.16 |
(1) | Represents less than 0.1 million shares.
| The following table sets forth the stock option and share appreciation rights (“SARs”) activity on grants related directly to the Starz Business’s employees during the year ended March 31, 2024:
|  | Stock Options and SARs |
|  | Lionsgate Class B Non-Voting Shares |
|  | Number of Shares |  |  | Weighted- Average Exercise Price |  |  | Weighted- Average Remaining Contractual Term (years) |  |  | Aggregate Intrinsic Value (2) |
|  | (Amounts in millions, except for weighted-average exercise price and years) |
Outstanding at March 31, 2023 |  |  | 1.5 |  |  | $ | 11.89 |  |  |  |  |  |  |  |  |
Granted |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Exercised |  |  | — | (1) |  | $ | 7.13 |  |  |  |  |  |  |  |  |
Forfeited or expired |  |  | (0.2 | ) |  | $ | 15.56 |  |  |  |  |  |  |  |  |
Outstanding at March 31, 2024 |  |  | 1.3 |  |  | $ | 11.14 |  |  |  | 4.78 |  |  | $ | 0.4 |
Vested or expected to vest at March 31, 2024 |  |  | 1.3 |  |  | $ | 11.14 |  |  |  | 4.78 |  |  | $ | 0.4 |
Exercisable at March 31, 2024 |  |  | 1.3 |  |  | $ | 11.14 |  |  |  | 4.78 |  |  | $ | 0.4 |
(1) | Represents less than 0.1 million shares.
(2) | The intrinsic value is calculated for each in-the-money stock option and SAR as the difference between the closing price of Lionsgate’s common stock on March 31, 2024 and the exercise price.
Summary Of Weighted Average Grant-Date Fair Value Of Options Granted |  | The fair value of each option award is estimated on the date of grant using a closed-form option valuation model (Black-Scholes). The following table presents the weighted average grant-date fair value of options granted in the year ended March 31, 2022 and the weighted average applicable assumptions used in the Black-Scholes option-pricing model for stock options and share-appreciation rights granted during the years then ended (no options or share-appreciation rights granted in the years ended March 31, 2024 or 2023):
|  | Year Ended March 31, |
|  | 2022 |
Weighted average fair value of grants |  | $ | 8.16 |
Weighted average assumptions: |  |  |  |
Risk-free interest rate (1) |  |  | 0.8 | %
Expected option lives (in years) (2) |  |  | 3.5 years |
Expected volatility for options (3) |  |  | 42 | %
Expected dividend yield (4) |  |  | 0 | %
(1) | The risk-free rate assumed in valuing the options is based on the U.S. Treasury Yield curve in effect applied against the expected term of the option at the time of the grant.
(2) | The expected term of options granted represents the period of time that options granted are expected to be outstanding.
(3) | Expected volatilities are based on implied volatilities from traded options on Lionsgate’s shares, historical volatility of Lionsgate’s shares and other factors.
(4) | The expected dividend yield is estimated by dividing the expected annual dividend by the market price of the Lionsgate’s shares at the date of grant.
Summary Of Restricted Share Unit And Restricted Stock Activity |  | The following table sets forth the restricted share unit activity on grants related directly to Starz Business employees during the year ended March 31, 2024:
|  | Restricted Share Units |
|  | Lionsgate Class B Non-Voting Shares |  |  | Weighted- Average Grant- Date Fair Value |
|  | (Amounts in millions, except for weighted-average grant date fair value) |
Outstanding at March 31, 2023 |  |  | 3.2 |  |  | $ | 9.46 |
Granted |  |  | 3.1 |  |  | $ | 8.16 |
Vested |  |  | (2.4 | ) |  | $ | 9.23 |
Forfeited |  |  | (0.5 | ) |  | $ | 8.49 |
Outstanding at March 31, 2024 |  |  | 3.4 |  |  | $ | 8.62 |
The fair values of restricted share units are determined based on the market value of the shares on the date of grant. The total fair value of restricted share units vested during the year ended March 31, 2024 was $22.0 million (2023 - $16.7 million, 2022 - $16.8 million).
Summary Of Total Remaining Unrecognized Compensation Cost |  | The following table summarizes the total remaining unrecognized compensation cost as of March 31, 2024 related to non-vested restricted share units and the weighted average remaining years over which the cost will be recognized. As of March 31, 2024, there was no remaining unrecognized compensation cost related to non-vested stock options.
|  | Total Unrecognized Compensation Cost |  |  | Weighted Average Remaining Years |
|  | (Amounts in millions) |  |  |  |
Restricted Share Units |  | $ | 14.0 |  |  |  | 1.3 |
Under Lionsgate’s stock option and long term incentive plans, Lionsgate withholds shares to satisfy minimum statutory federal, state and local tax withholding obligations arising from the vesting of restricted share units. During the year ended March 31, 2024, 0.9 million shares (2023 — 0.7 million shares, 2022 — 0.5 million shares) were withheld upon the vesting of restricted share units.

X
- Definition Disclosure in tabular form of allocated share based compensation before tax [table text block]. + References No definition available. + Details
Name: | lgfa_DisclosureInTabularFormOfAllocatedShareBasedCompensationBeforeTaxTableTextBlock
Namespace Prefix: | lgfa_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure in tabular form of remaining unrecognized share based compensation [table text block]. + References No definition available. + Details
Name: | lgfa_DisclosureInTabularFormOfRemainingUnrecognizedShareBasedCompensationTableTextBlock
Namespace Prefix: | lgfa_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | dei_LegalEntityAxis=lgfa_StarzBusinessOfLionsGateEntertainmentCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |